Lüscher T F, Lie J T, Stanson A W, Houser O W, Hollier L H, Sheps S G
Department of Physiology and Biophysics, Mayo Clinic, Rochester, MN 55905.
Mayo Clin Proc. 1987 Oct;62(10):931-52. doi: 10.1016/s0025-6196(12)65051-4.
Fibromuscular dysplasia is a nonatherosclerotic, noninflammatory vascular disease that involves primarily the renal and internal carotid arteries and less often the vertebral, iliac, subclavian, and visceral arteries. Although its pathogenesis is not completely understood, humoral, mechanical, and genetic factors as well as mural ischemia may play a role. The natural history is relatively benign, with progression occurring in only a minority of the patients. Typical clinical manifestations are renovascular hypertension, stroke, subarachnoid hemorrhage, abdominal angina, or claudication of the legs or arms. In patients with symptoms, percutaneous transluminal angioplasty has emerged as the treatment of choice in most involved vascular beds.
纤维肌性发育异常是一种非动脉粥样硬化、非炎症性血管疾病,主要累及肾动脉和颈内动脉,较少累及椎动脉、髂动脉、锁骨下动脉和内脏动脉。尽管其发病机制尚未完全明确,但体液、机械、遗传因素以及血管壁缺血可能起作用。其自然病程相对良性,只有少数患者会出现病情进展。典型的临床表现为肾血管性高血压、中风、蛛网膜下腔出血、腹部绞痛或下肢或上肢间歇性跛行。对于有症状的患者,经皮腔内血管成形术已成为大多数受累血管床的首选治疗方法。